Active ingredientLarotaxelCat. No. P-L019-001CAS 156294-36-9Family · Pharmaceutical analytical standards
Larotaxel
An anticancer drug of the taxane family, which blocks cell division by acting on microtubules. In the 2000s it was studied against several solid tumours, including lung and bladder cancer, but clinical development was stopped before approval. This family brings together the active ingredient and labelled standards.
Did you know?Compared with paclitaxel and docetaxel, studies suggested it could overcome some resistance mechanisms and penetrate the central nervous system, which the older taxanes struggle to reach.
Go to the active ingredient →Active ingredientLarotaxelCat. No. P-L019-001CAS 156294-36-9
Isotopically labelledLarotaxel-d3Cat. No. P-L019-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.